{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:51:33Z","timestamp":1723337493811},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Three years after prostatectomy, a 78-year-old man with initial high-risk prostate cancer and new increasing prostate-specific antigen levels underwent <jats:sup>68<\/jats:sup>Ga-prostate-specific membrane antigen (PSMA) PET\/CT. Imaging revealed PSMA-positive pelvic, ascending retroperitoneal and left supraclavicular lymph nodes consistent with metastases. Additionally, there was PSMA-positive lymphadenopathy (hilar and mediastinal) and pulmonary changes (fibrotic and nodular) in which histopathology excluded metastases. A lymphocyte proliferation test was indicative of beryllium sensitization. Chronic beryllium lung disease\u2014a multisystem granulomatous inflammatory disease mainly affecting the lungs\u2014could be established in this patient with occupational exposure to beryllium. This case shows that manifestations of berylliosis can also be PSMA positive.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002323","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T21:12:58Z","timestamp":1540415578000},"page":"64-65","source":"Crossref","is-referenced-by-count":4,"title":["Prostate-Specific Membrane Antigen\u2013Positive Manifestations of Chronic Beryllium Lung Disease"],"prefix":"10.1097","volume":"44","author":[{"given":"Kai","family":"Huang","sequence":"first","affiliation":[{"name":"Nuclear Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander DJ","family":"Baur","sequence":"additional","affiliation":[{"name":"Radiology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Furth","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1148\/radiology.190.3.8115636","article-title":"Beryllium disease: assessment with CT","volume":"190","year":"1994","journal-title":"Radiology"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(04)15523-2","article-title":"Beryllium exposure and chronic beryllium disease","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"bib3-20230925","first-page":"990","article-title":"Clinical application of beryllium lymphocyte proliferation testing","volume":"10","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/RCT.0b013e3181ef214e","article-title":"Chronic beryllium disease: computed tomographic findings","volume":"34","year":"2010","journal-title":"J Comput Assist Tomogr"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0034-1377059","article-title":"Sarcoidosis and chronic beryllium disease: similarities and differences","volume":"35","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","article-title":"PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions","volume":"40","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib7-20230925","article-title":"68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography\/computed tomography for prostate cancer: a systematic review and meta-analysis","year":"2016","journal-title":"Eur Urol Focus"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.eururo.2016.06.021","article-title":"Sensitivity, specificity, and predictors of positive (68)Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis","volume":"70","year":"2016","journal-title":"Eur Urol"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/RLU.0000000000001582","article-title":"Solitary PSMA-positive pulmonary metastasis in biochemical relapse of prostate cancer","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1097\/RLU.0000000000001176","article-title":"Widespread metastatic prostate carcinoma shown by 68Ga-PSMA PET\/CT","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s00259-017-3780-7","article-title":"Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40644-018-0154-8","article-title":"(68)Ga-PSMA-PET\/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer","volume":"18","year":"2018","journal-title":"Cancer Imaging"},{"key":"bib13-20230925","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2967\/jnumed.115.164442","article-title":"68Ga-PSMA-HBED-CC PET for differential diagnosis of suggestive lung lesions in patients with prostate cancer","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"key":"bib14-20230925","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/RLU.0000000000001139","article-title":"Elevated 68Ga prostate-specific membrane antigen activity in metastatic non-small cell lung cancer","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib15-20230925","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1016\/j.clgc.2018.03.009","article-title":"Primary lung adenocarcinoma with 68gallium prostate-specific membrane antigen-PET\/CT scan avidity in a patient on surveillance after prostatectomy","volume":"16","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"bib16-20230925","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1097\/RLU.0000000000001568","article-title":"Pulmonary opacities and bronchiectasis avid on 68Ga-PSMA PET","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib17-20230925","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/RLU.0000000000001543","article-title":"PSMA uptake in mediastinal sarcoidosis","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib18-20230925","first-page":"65","article-title":"A potential pitfall in the use of (68)Ga-PSMA PET\/CT: anthracosis","volume":"36","year":"2017","journal-title":"Rev Esp Med Nucl Imagen Mol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201901000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:12:54Z","timestamp":1695618774000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201901000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002323","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}